Skip to content

In vitro coagulation dynamics of conformational changes in ADAMTS13

In vitro coagulation dynamics of conformational changes in ADAMTS13 - CODA-13

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON50123
Enrollment
24
Registered
2020-09-29
Start date
2021-02-11
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute traumatic coagulopathy Trauma-induced coagulopathy

Interventions

None listed

Sponsors

Academisch Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Healthy male volunteers (age: 18-35 years)

Exclusion criteria

Exclusion criteria: - Participation in a scientific intervention study in the last 3 months - No informed consent - History of coagulation disorders - Active use of prescription medication - Use of anticoagulant medication, including aspirin - History of liver disease - History of chronic transmittable disease - History of alcohol, smoking or drug abuse - History of alcohol/drug use in past 24 hours

Design outcomes

Primary

MeasureTime frame
In vitro: whether open conformation of ADAMTS13 is associated with hyperfibrino(geno)lysis determined by ROTEM, coagulation proteins measurements, and/or other whole blood or plasmatic coagulation tests.

Secondary

MeasureTime frame
Secondary outcomes will be related to factors contributing to open conformation ADAMTS13 and the effects of ADAMTS13 and/or hyperfibrino(geno)lysis on coagulation components such as platelets.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)